| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | 5-diphosphoinositol pentakisphosphate 1-kinase activity | 8.01e-06 | 2 | 57 | 2 | GO:0033857 | |
| GeneOntologyMolecularFunction | inositol hexakisphosphate 3-kinase activity | 4.79e-05 | 4 | 57 | 2 | GO:0052724 | |
| GeneOntologyMolecularFunction | inositol hexakisphosphate 1-kinase activity | 4.79e-05 | 4 | 57 | 2 | GO:0052723 | |
| GeneOntologyMolecularFunction | inositol hexakisphosphate 5-kinase activity | 7.96e-05 | 5 | 57 | 2 | GO:0000832 | |
| GeneOntologyMolecularFunction | diphosphoinositol pentakisphosphate kinase activity | 7.96e-05 | 5 | 57 | 2 | GO:0000829 | |
| GeneOntologyMolecularFunction | inositol hexakisphosphate kinase activity | 7.96e-05 | 5 | 57 | 2 | GO:0000828 | |
| GeneOntologyMolecularFunction | inositol-1,3,4,5,6-pentakisphosphate kinase activity | 7.96e-05 | 5 | 57 | 2 | GO:0000827 | |
| GeneOntologyMolecularFunction | G protein-coupled glutamate receptor activity | 2.85e-04 | 9 | 57 | 2 | GO:0098988 | |
| GeneOntologyMolecularFunction | adenylate cyclase inhibiting G protein-coupled glutamate receptor activity | 2.85e-04 | 9 | 57 | 2 | GO:0001640 | |
| GeneOntologyMolecularFunction | TAP complex binding | 2.85e-04 | 9 | 57 | 2 | GO:0062061 | |
| GeneOntologyMolecularFunction | CD8 receptor binding | 2.85e-04 | 9 | 57 | 2 | GO:0042610 | |
| GeneOntologyMolecularFunction | TAP1 binding | 3.55e-04 | 10 | 57 | 2 | GO:0046978 | |
| GeneOntologyMolecularFunction | TAP2 binding | 3.55e-04 | 10 | 57 | 2 | GO:0046979 | |
| GeneOntologyMolecularFunction | TAP binding | 3.55e-04 | 10 | 57 | 2 | GO:0046977 | |
| GeneOntologyMolecularFunction | inositol phosphate kinase activity | 4.33e-04 | 11 | 57 | 2 | GO:0180030 | |
| GeneOntologyMolecularFunction | beta-2-microglobulin binding | 5.19e-04 | 12 | 57 | 2 | GO:0030881 | |
| GeneOntologyMolecularFunction | natural killer cell lectin-like receptor binding | 1.06e-03 | 17 | 57 | 2 | GO:0046703 | |
| GeneOntologyMolecularFunction | T cell receptor binding | 1.47e-03 | 20 | 57 | 2 | GO:0042608 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 1.85e-03 | 85 | 57 | 3 | GO:0038024 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 2.68e-03 | 27 | 57 | 2 | GO:0008066 | |
| GeneOntologyMolecularFunction | MHC class I protein binding | 3.76e-03 | 32 | 57 | 2 | GO:0042288 | |
| GeneOntologyBiologicalProcess | positive regulation of RNA splicing | RBMXL1 RBMY1A1 RBMX RBMY1C RBMY1F RBMY1D RBMY1B RBMY1E HNRNPK | 8.63e-14 | 63 | 56 | 9 | GO:0033120 |
| GeneOntologyBiologicalProcess | positive regulation of mRNA splicing, via spliceosome | 2.88e-13 | 44 | 56 | 8 | GO:0048026 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA processing | 7.25e-13 | 49 | 56 | 8 | GO:0050685 | |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | RBMXL1 RBM4 RBMY1A1 RBMX RBMY1C RBMY1F RBMY1D RBMY1B RBMY1E HNRNPK | 1.79e-12 | 129 | 56 | 10 | GO:0048024 |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | RBMXL1 RBM4 RBMY1A1 RBMX RBMY1C RBMY1F RBMY1D RBMY1B RBMY1E HNRNPK | 1.37e-11 | 158 | 56 | 10 | GO:0050684 |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | RBMXL1 RBM4 RBMY1A1 RBMX RBMY1C RBMY1F RBMY1D RBMY1B RBMY1E HNRNPK | 1.99e-10 | 207 | 56 | 10 | GO:0043484 |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | RBMXL1 RBM4B RBM4 RBMY1A1 RBMX RBMY1C RBMY1F RBMY1D RBMY1B RBMY1E HNRNPK | 2.74e-09 | 358 | 56 | 11 | GO:0000398 |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | RBMXL1 RBM4B RBM4 RBMY1A1 RBMX RBMY1C RBMY1F RBMY1D RBMY1B RBMY1E HNRNPK | 2.74e-09 | 358 | 56 | 11 | GO:0000377 |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | RBMXL1 RBM4B RBM4 RBMY1A1 RBMX RBMY1C RBMY1F RBMY1D RBMY1B RBMY1E HNRNPK | 3.07e-09 | 362 | 56 | 11 | GO:0000375 |
| GeneOntologyBiologicalProcess | RNA splicing | NRDE2 RBMXL1 RBM4B RBM4 RBMY1A1 RBMX RBMY1C RBMY1F RBMY1D RBMY1B RBMY1E HNRNPK | 8.00e-09 | 502 | 56 | 12 | GO:0008380 |
| GeneOntologyBiologicalProcess | mRNA processing | NRDE2 RBMXL1 RBM4B RBM4 RBMY1A1 RBMX RBMY1C RBMY1F RBMY1D RBMY1B RBMY1E HNRNPK | 2.24e-08 | 551 | 56 | 12 | GO:0006397 |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | NRDE2 RBMXL1 RBM4 RBMY1A1 RBMX RBMY1C RBMY1F RBMY1D RBMY1B RBMY1E HNRNPK | 2.47e-08 | 443 | 56 | 11 | GO:1903311 |
| GeneOntologyBiologicalProcess | positive regulation of mRNA metabolic process | 4.68e-07 | 259 | 56 | 8 | GO:1903313 | |
| GeneOntologyBiologicalProcess | mRNA metabolic process | NRDE2 SMG8 RBMXL1 RBM4B RBM4 RBMY1A1 RBMX RBMY1C RBMY1F RBMY1D RBMY1B RBMY1E HNRNPK | 7.78e-07 | 917 | 56 | 13 | GO:0016071 |
| GeneOntologyBiologicalProcess | synapse organization | TANC2 KY RBMX SIPA1L1 PRICKLE2 BCAN SRGAP2 GRM5 RPH3A HNRNPK | 1.37e-05 | 685 | 56 | 10 | GO:0050808 |
| GeneOntologyBiologicalProcess | sex differentiation | 4.49e-05 | 352 | 56 | 7 | GO:0007548 | |
| GeneOntologyBiologicalProcess | reproductive structure development | 7.64e-05 | 383 | 56 | 7 | GO:0048608 | |
| GeneOntologyBiologicalProcess | reproductive system development | 8.28e-05 | 388 | 56 | 7 | GO:0061458 | |
| GeneOntologyBiologicalProcess | positive regulation of gene expression | NRDE2 RBMXL1 RBM4B RBM4 RBMY1A1 RBMX RBMY1C RBMY1F HLA-F RBMY1D RBMY1B RBMY1E HNRNPK | 1.03e-04 | 1446 | 56 | 13 | GO:0010628 |
| GeneOntologyBiologicalProcess | regulation of postsynapse organization | 1.45e-04 | 185 | 56 | 5 | GO:0099175 | |
| GeneOntologyBiologicalProcess | postsynapse organization | 2.00e-04 | 313 | 56 | 6 | GO:0099173 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent | 2.01e-04 | 8 | 56 | 2 | GO:0002485 | |
| GeneOntologyBiologicalProcess | male sex differentiation | 2.04e-04 | 199 | 56 | 5 | GO:0046661 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway | 2.57e-04 | 9 | 56 | 2 | GO:0007196 | |
| GeneOntologyBiologicalProcess | cell junction organization | TANC2 KY RBMX SIPA1L1 PRICKLE2 BCAN SRGAP2 GRM5 RPH3A HNRNPK | 2.59e-04 | 974 | 56 | 10 | GO:0034330 |
| GeneOntologyBiologicalProcess | negative regulation of innate immune response | 2.60e-04 | 114 | 56 | 4 | GO:0045824 | |
| GeneOntologyBiologicalProcess | excitatory synapse assembly | 2.65e-04 | 46 | 56 | 3 | GO:1904861 | |
| GeneOntologyBiologicalProcess | inositol metabolic process | 3.21e-04 | 10 | 56 | 2 | GO:0006020 | |
| GeneOntologyBiologicalProcess | inositol phosphate metabolic process | 3.81e-04 | 52 | 56 | 3 | GO:0043647 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 3.81e-04 | 52 | 56 | 3 | GO:0031342 | |
| GeneOntologyBiologicalProcess | regulation of alternative mRNA splicing, via spliceosome | 5.53e-04 | 59 | 56 | 3 | GO:0000381 | |
| GeneOntologyBiologicalProcess | RNA processing | NRDE2 RBMXL1 RBM4B RBM4 RBMY1A1 RBMX RBMY1C RBMY1F RBMY1D RBMY1B RBMY1E HNRNPK | 5.81e-04 | 1500 | 56 | 12 | GO:0006396 |
| GeneOntologyBiologicalProcess | dendritic spine development | 5.83e-04 | 141 | 56 | 4 | GO:0060996 | |
| GeneOntologyBiologicalProcess | regulation of synapse organization | 6.18e-04 | 387 | 56 | 6 | GO:0050807 | |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | 6.87e-04 | 395 | 56 | 6 | GO:0050803 | |
| GeneOntologyBiologicalProcess | negative regulation of response to biotic stimulus | 7.54e-04 | 151 | 56 | 4 | GO:0002832 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent | 8.48e-04 | 16 | 56 | 2 | GO:0002486 | |
| GeneOntologyBiologicalProcess | G protein-coupled glutamate receptor signaling pathway | 8.48e-04 | 16 | 56 | 2 | GO:0007216 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway | 9.59e-04 | 17 | 56 | 2 | GO:0002484 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class Ib | 9.59e-04 | 17 | 56 | 2 | GO:0002476 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class Ib | 1.08e-03 | 18 | 56 | 2 | GO:0002428 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen via MHC class I | 1.08e-03 | 18 | 56 | 2 | GO:0042590 | |
| GeneOntologyBiologicalProcess | gonad development | 1.16e-03 | 292 | 56 | 5 | GO:0008406 | |
| GeneOntologyBiologicalProcess | male gonad development | 1.20e-03 | 171 | 56 | 4 | GO:0008584 | |
| GeneOntologyBiologicalProcess | development of primary male sexual characteristics | 1.22e-03 | 172 | 56 | 4 | GO:0046546 | |
| GeneOntologyBiologicalProcess | development of primary sexual characteristics | 1.25e-03 | 297 | 56 | 5 | GO:0045137 | |
| GeneOntologyBiologicalProcess | alternative mRNA splicing, via spliceosome | 1.30e-03 | 79 | 56 | 3 | GO:0000380 | |
| GeneOntologyBiologicalProcess | detection of bacterium | 1.33e-03 | 20 | 56 | 2 | GO:0016045 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic density assembly | 1.47e-03 | 21 | 56 | 2 | GO:0099151 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte mediated immunity | 1.49e-03 | 83 | 56 | 3 | GO:0002707 | |
| GeneOntologyBiologicalProcess | detection of other organism | 1.77e-03 | 23 | 56 | 2 | GO:0098543 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I | 1.77e-03 | 23 | 56 | 2 | GO:0019885 | |
| GeneOntologyBiologicalProcess | hematopoietic progenitor cell differentiation | 2.01e-03 | 197 | 56 | 4 | GO:0002244 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen | 2.09e-03 | 25 | 56 | 2 | GO:0002483 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation via MHC class Ib | 2.09e-03 | 25 | 56 | 2 | GO:0002475 | |
| GeneOntologyBiologicalProcess | entrainment of circadian clock by photoperiod | 2.09e-03 | 25 | 56 | 2 | GO:0043153 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic specialization assembly | 2.26e-03 | 26 | 56 | 2 | GO:0099150 | |
| GeneOntologyBiologicalProcess | regulation of excitatory synapse assembly | 2.26e-03 | 26 | 56 | 2 | GO:1904889 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated immunity | 2.27e-03 | 96 | 56 | 3 | GO:0002704 | |
| GeneOntologyCellularComponent | spliceosomal complex | RBMXL1 RBMY1A1 RBMX RBMY1C RBMY1F RBMY1D RBMY1B RBMY1E HNRNPK | 6.39e-09 | 215 | 57 | 9 | GO:0005681 |
| GeneOntologyCellularComponent | glutamatergic synapse | TANC2 RASGRF2 TSPOAP1 INPP4A RBMX SIPA1L1 PRICKLE2 BCAN SRGAP2 GRM5 GRM7 HNRNPK | 1.64e-06 | 817 | 57 | 12 | GO:0098978 |
| GeneOntologyCellularComponent | asymmetric synapse | 5.29e-06 | 477 | 57 | 9 | GO:0032279 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 1.11e-05 | 523 | 57 | 9 | GO:0098984 | |
| GeneOntologyCellularComponent | postsynapse | TANC2 INPP4A RBMX SIPA1L1 PRICKLE2 SRGAP2 GRM5 GRM7 RPH3A GPR179 HNRNPK BAALC | 1.55e-05 | 1018 | 57 | 12 | GO:0098794 |
| GeneOntologyCellularComponent | postsynaptic density | 2.89e-05 | 451 | 57 | 8 | GO:0014069 | |
| GeneOntologyCellularComponent | supraspliceosomal complex | 4.37e-05 | 4 | 57 | 2 | GO:0044530 | |
| GeneOntologyCellularComponent | dendritic spine | 5.01e-05 | 242 | 57 | 6 | GO:0043197 | |
| GeneOntologyCellularComponent | neuron spine | 5.61e-05 | 247 | 57 | 6 | GO:0044309 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 6.24e-05 | 503 | 57 | 8 | GO:0099572 | |
| GeneOntologyCellularComponent | male germ cell nucleus | 8.93e-05 | 86 | 57 | 4 | GO:0001673 | |
| GeneOntologyCellularComponent | dendrite | TANC2 SIPA1L1 BCAN SRGAP2 TMEM222 GRM5 GRM7 RPH3A GPR179 HNRNPK | 9.64e-05 | 858 | 57 | 10 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | TANC2 SIPA1L1 BCAN SRGAP2 TMEM222 GRM5 GRM7 RPH3A GPR179 HNRNPK | 9.83e-05 | 860 | 57 | 10 | GO:0097447 |
| GeneOntologyCellularComponent | MHC class Ib protein complex | 1.52e-04 | 7 | 57 | 2 | GO:0032398 | |
| GeneOntologyCellularComponent | germ cell nucleus | 2.56e-04 | 113 | 57 | 4 | GO:0043073 | |
| GeneOntologyCellularComponent | MHC class I protein complex | 3.24e-04 | 10 | 57 | 2 | GO:0042612 | |
| GeneOntologyCellularComponent | somatodendritic compartment | TANC2 SIPA1L1 TMPRSS5 BCAN SRGAP2 TMEM222 GRM5 GRM7 RPH3A GPR179 HNRNPK | 4.17e-04 | 1228 | 57 | 11 | GO:0036477 |
| GeneOntologyCellularComponent | MHC class I peptide loading complex | 6.51e-04 | 14 | 57 | 2 | GO:0042824 | |
| GeneOntologyCellularComponent | cis-Golgi network membrane | 9.68e-04 | 17 | 57 | 2 | GO:0033106 | |
| GeneOntologyCellularComponent | Golgi medial cisterna | 1.78e-03 | 23 | 57 | 2 | GO:0005797 | |
| GeneOntologyCellularComponent | MHC protein complex | 2.28e-03 | 26 | 57 | 2 | GO:0042611 | |
| GeneOntologyCellularComponent | recycling endosome membrane | 3.55e-03 | 112 | 57 | 3 | GO:0055038 | |
| GeneOntologyCellularComponent | endocytic vesicle | 3.90e-03 | 384 | 57 | 5 | GO:0030139 | |
| GeneOntologyCellularComponent | lumenal side of endoplasmic reticulum membrane | 4.10e-03 | 35 | 57 | 2 | GO:0098553 | |
| GeneOntologyCellularComponent | ribonucleoprotein complex | RBMXL1 RBMY1A1 RBMX RBMY1C RBMY1F RBMY1D RBMY1B RBMY1E HNRNPK | 4.74e-03 | 1194 | 57 | 9 | GO:1990904 |
| GeneOntologyCellularComponent | postsynaptic membrane | 4.88e-03 | 405 | 57 | 5 | GO:0045211 | |
| GeneOntologyCellularComponent | synaptic membrane | 4.99e-03 | 583 | 57 | 6 | GO:0097060 | |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 5.86e-03 | 42 | 57 | 2 | GO:0070971 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 6.21e-03 | 269 | 57 | 4 | GO:0036464 | |
| GeneOntologyCellularComponent | lumenal side of membrane | 7.60e-03 | 48 | 57 | 2 | GO:0098576 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 7.77e-03 | 287 | 57 | 4 | GO:0035770 | |
| Domain | RBM1CTR | 1.18e-17 | 8 | 56 | 7 | PF08081 | |
| Domain | RBM1CTR | 1.18e-17 | 8 | 56 | 7 | IPR012604 | |
| Domain | RRM_1 | 1.07e-08 | 208 | 56 | 9 | PF00076 | |
| Domain | RRM | 1.54e-08 | 217 | 56 | 9 | SM00360 | |
| Domain | RRM_dom | 2.28e-08 | 227 | 56 | 9 | IPR000504 | |
| Domain | RRM | 2.55e-08 | 230 | 56 | 9 | PS50102 | |
| Domain | Nucleotide-bd_a/b_plait | 6.85e-08 | 258 | 56 | 9 | IPR012677 | |
| Domain | - | 6.26e-07 | 244 | 56 | 8 | 3.30.70.330 | |
| Domain | GPCR_3 | 3.27e-05 | 21 | 56 | 3 | IPR000337 | |
| Domain | 7tm_3 | 3.78e-05 | 22 | 56 | 3 | PF00003 | |
| Domain | G_PROTEIN_RECEP_F3_2 | 3.78e-05 | 22 | 56 | 3 | PS00980 | |
| Domain | G_PROTEIN_RECEP_F3_3 | 3.78e-05 | 22 | 56 | 3 | PS00981 | |
| Domain | G_PROTEIN_RECEP_F3_1 | 3.78e-05 | 22 | 56 | 3 | PS00979 | |
| Domain | G_PROTEIN_RECEP_F3_4 | 3.78e-05 | 22 | 56 | 3 | PS50259 | |
| Domain | GPCR_3_C | 3.78e-05 | 22 | 56 | 3 | IPR017978 | |
| Domain | EGF | 7.14e-05 | 235 | 56 | 6 | SM00181 | |
| Domain | Acid_Pase_AS | 1.31e-04 | 6 | 56 | 2 | IPR033379 | |
| Domain | MHC_I_a_C | 1.31e-04 | 6 | 56 | 2 | IPR010579 | |
| Domain | MHC_I_C | 1.31e-04 | 6 | 56 | 2 | PF06623 | |
| Domain | HIS_ACID_PHOSPHAT_2 | 1.84e-04 | 7 | 56 | 2 | PS00778 | |
| Domain | HIS_ACID_PHOSPHAT_1 | 1.84e-04 | 7 | 56 | 2 | PS00616 | |
| Domain | EGF_Ca-bd_CS | 2.04e-04 | 97 | 56 | 4 | IPR018097 | |
| Domain | EGF_CA | 2.21e-04 | 99 | 56 | 4 | PS01187 | |
| Domain | ASX_HYDROXYL | 2.30e-04 | 100 | 56 | 4 | PS00010 | |
| Domain | His_Pase_clade-2 | 2.44e-04 | 8 | 56 | 2 | IPR000560 | |
| Domain | His_Phos_2 | 2.44e-04 | 8 | 56 | 2 | PF00328 | |
| Domain | GPCR_3_mtglu_rcpt | 2.44e-04 | 8 | 56 | 2 | IPR000162 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 2.87e-04 | 106 | 56 | 4 | IPR000152 | |
| Domain | KH_dom_type_1 | 3.10e-04 | 44 | 56 | 3 | IPR004088 | |
| Domain | EGF_CA | 4.90e-04 | 122 | 56 | 4 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 5.21e-04 | 124 | 56 | 4 | IPR001881 | |
| Domain | EGF | 5.53e-04 | 126 | 56 | 4 | PF00008 | |
| Domain | CCP | 5.68e-04 | 54 | 56 | 3 | SM00032 | |
| Domain | SUSHI | 6.32e-04 | 56 | 56 | 3 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 6.66e-04 | 57 | 56 | 3 | IPR000436 | |
| Domain | NCD3G | 6.74e-04 | 13 | 56 | 2 | PF07562 | |
| Domain | GPCR_3_9-Cys_dom | 6.74e-04 | 13 | 56 | 2 | IPR011500 | |
| Domain | EGF_3 | 6.85e-04 | 235 | 56 | 5 | PS50026 | |
| Domain | Ig/MHC_CS | 7.01e-04 | 58 | 56 | 3 | IPR003006 | |
| Domain | IG_MHC | 7.74e-04 | 60 | 56 | 3 | PS00290 | |
| Domain | GPCR_3_CS | 7.85e-04 | 14 | 56 | 2 | IPR017979 | |
| Domain | EGF-like_dom | 8.88e-04 | 249 | 56 | 5 | IPR000742 | |
| Domain | EGF_1 | 9.88e-04 | 255 | 56 | 5 | PS00022 | |
| Domain | EGF-like_CS | 1.10e-03 | 261 | 56 | 5 | IPR013032 | |
| Domain | EGF_2 | 1.17e-03 | 265 | 56 | 5 | PS01186 | |
| Domain | Growth_fac_rcpt_ | 1.23e-03 | 156 | 56 | 4 | IPR009030 | |
| Domain | His_PPase_superfam | 1.62e-03 | 20 | 56 | 2 | IPR029033 | |
| Domain | - | 1.62e-03 | 20 | 56 | 2 | 3.40.50.1240 | |
| Domain | MHC_I | 1.79e-03 | 21 | 56 | 2 | PF00129 | |
| Domain | MHC_I_a_a1/a2 | 1.79e-03 | 21 | 56 | 2 | IPR001039 | |
| Domain | RRM_dom_euk | 2.15e-03 | 23 | 56 | 2 | IPR003954 | |
| Domain | RRM_1 | 2.15e-03 | 23 | 56 | 2 | SM00361 | |
| Domain | zf-CCHC | 2.15e-03 | 23 | 56 | 2 | PF00098 | |
| Domain | EGF_CA | 2.19e-03 | 86 | 56 | 3 | PF07645 | |
| Domain | - | 2.34e-03 | 24 | 56 | 2 | 3.30.500.10 | |
| Domain | MHC_I-like_Ag-recog | 2.34e-03 | 24 | 56 | 2 | IPR011161 | |
| Domain | - | 2.53e-03 | 25 | 56 | 2 | 3.10.250.10 | |
| Domain | SRCR_1 | 2.74e-03 | 26 | 56 | 2 | PS00420 | |
| Domain | cEGF | 2.74e-03 | 26 | 56 | 2 | IPR026823 | |
| Domain | - | 2.74e-03 | 26 | 56 | 2 | 4.10.60.10 | |
| Domain | SRCR_2 | 2.74e-03 | 26 | 56 | 2 | PS50287 | |
| Domain | cEGF | 2.74e-03 | 26 | 56 | 2 | PF12662 | |
| Domain | SRCR-like_dom | 2.74e-03 | 26 | 56 | 2 | IPR017448 | |
| Domain | SRCR | 2.95e-03 | 27 | 56 | 2 | IPR001190 | |
| Domain | hEGF | 3.17e-03 | 28 | 56 | 2 | PF12661 | |
| Domain | - | 3.52e-03 | 663 | 56 | 7 | 2.60.40.10 | |
| Domain | ZF_CCHC | 4.93e-03 | 35 | 56 | 2 | PS50158 | |
| Pathway | WP_MRNA_PROCESSING | 8.49e-06 | 451 | 44 | 9 | MM15946 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_MIR1_2_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 1.42e-04 | 6 | 44 | 2 | M47468 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 1.98e-04 | 7 | 44 | 2 | M47530 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 1.98e-04 | 7 | 44 | 2 | M47582 | |
| Pathway | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | 3.38e-04 | 9 | 44 | 2 | MM14527 | |
| Pathway | REACTOME_SYNTHESIS_OF_PYROPHOSPHATES_IN_THE_CYTOSOL | 4.22e-04 | 10 | 44 | 2 | M27051 | |
| Pathway | REACTOME_SYNTHESIS_OF_PYROPHOSPHATES_IN_THE_CYTOSOL | 4.22e-04 | 10 | 44 | 2 | MM14709 | |
| Pathway | REACTOME_INOSITOL_PHOSPHATE_METABOLISM | 4.45e-04 | 48 | 44 | 3 | MM14589 | |
| Pathway | REACTOME_INOSITOL_PHOSPHATE_METABOLISM | 4.45e-04 | 48 | 44 | 3 | M26964 | |
| Pathway | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | 5.14e-04 | 11 | 44 | 2 | M525 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 6.16e-04 | 12 | 44 | 2 | M47529 | |
| Pathway | WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE | 9.74e-04 | 15 | 44 | 2 | M39442 | |
| Pathway | WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE | 9.74e-04 | 15 | 44 | 2 | MM15845 | |
| Pathway | REACTOME_ER_PHAGOSOME_PATHWAY | 1.41e-03 | 18 | 44 | 2 | MM14525 | |
| Pathway | BIOCARTA_CTL_PATHWAY | 1.75e-03 | 20 | 44 | 2 | MM1374 | |
| Pubmed | 1.15e-16 | 7 | 58 | 6 | 8269511 | ||
| Pubmed | 1.51e-14 | 12 | 58 | 6 | 9598316 | ||
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 10749975 | ||
| Pubmed | 6.48e-14 | 6 | 58 | 5 | 15184870 | ||
| Pubmed | Degeneracy in human multicopy RBM (YRRM), a candidate spermatogenesis gene. | 2.26e-13 | 7 | 58 | 5 | 8875892 | |
| Pubmed | Evolutionary strata on the mouse X chromosome correspond to strata on the human X chromosome. | 3.20e-11 | 15 | 58 | 5 | 14762062 | |
| Pubmed | An RBM homologue maps to the mouse Y chromosome and is expressed in germ cells. | 3.48e-11 | 5 | 58 | 4 | 8817321 | |
| Pubmed | 3.48e-11 | 5 | 58 | 4 | 20016065 | ||
| Pubmed | The role of human and mouse Y chromosome genes in male infertility. | 3.48e-11 | 5 | 58 | 4 | 11097427 | |
| Pubmed | Rapid evolution of mouse Y centromere repeat DNA belies recent sequence stability. | 3.48e-11 | 5 | 58 | 4 | 19737860 | |
| Pubmed | 1.04e-10 | 6 | 58 | 4 | 18239052 | ||
| Pubmed | Identification of target messenger RNA substrates for mouse RBMY. | 1.04e-10 | 6 | 58 | 4 | 18492746 | |
| Pubmed | Meiotic sex chromosome inactivation in male mice with targeted disruptions of Xist. | 1.04e-10 | 6 | 58 | 4 | 12356914 | |
| Pubmed | 1.04e-10 | 6 | 58 | 4 | 9499427 | ||
| Pubmed | 1.04e-10 | 6 | 58 | 4 | 15051956 | ||
| Pubmed | 2.43e-10 | 7 | 58 | 4 | 17001072 | ||
| Pubmed | The roles of RNA-binding proteins in spermatogenesis and male infertility. | 2.43e-10 | 7 | 58 | 4 | 10377282 | |
| Pubmed | MEX3A RBMXL1 RBM4B RBM4 RBMY1A1 RBMX RBMY1D RBMY1B RBMY1E HNRNPK | 2.93e-10 | 347 | 58 | 10 | 16033648 | |
| Pubmed | 4.85e-10 | 8 | 58 | 4 | 7479793 | ||
| Pubmed | 1.45e-09 | 10 | 58 | 4 | 10601091 | ||
| Pubmed | 1.45e-09 | 10 | 58 | 4 | 10332027 | ||
| Pubmed | 1.45e-09 | 10 | 58 | 4 | 9384609 | ||
| Pubmed | The role of Dby mRNA in early development of male mouse zygotes. | 3.41e-09 | 12 | 58 | 4 | 20543856 | |
| Pubmed | RBMY evolved on the Y chromosome from a ubiquitously transcribed X-Y identical gene. | 4.40e-09 | 3 | 58 | 3 | 10391207 | |
| Pubmed | GASZ promotes germ cell derivation from embryonic stem cells. | 4.92e-09 | 13 | 58 | 4 | 23816659 | |
| Pubmed | Absence of mDazl produces a final block on germ cell development at meiosis. | 6.88e-09 | 14 | 58 | 4 | 14611631 | |
| Pubmed | Loss of maternal Trim28 causes male-predominant early embryonic lethality. | 1.63e-08 | 17 | 58 | 4 | 28115466 | |
| Pubmed | Sex differences in sex chromosome gene expression in mouse brain. | 2.09e-08 | 18 | 58 | 4 | 12023983 | |
| Pubmed | 1.01e-07 | 26 | 58 | 4 | 35920200 | ||
| Pubmed | Lineage-specific biology revealed by a finished genome assembly of the mouse. | 2.23e-06 | 55 | 58 | 4 | 19468303 | |
| Pubmed | Potential dual functional roles of the Y-linked RBMY in hepatocarcinogenesis. | 2.73e-06 | 2 | 58 | 2 | 32473614 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 18981179 | ||
| Pubmed | The LARK/RBM4a protein is highly expressed in cerebellum as compared to cerebrum. | 2.73e-06 | 2 | 58 | 2 | 18708123 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 18941505 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 17702752 | ||
| Pubmed | Phylogenetic and molecular characterization of the splicing factor RBM4. | 2.73e-06 | 2 | 58 | 2 | 23527094 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 28126903 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 17690096 | ||
| Pubmed | 2.96e-06 | 59 | 58 | 4 | 11279525 | ||
| Pubmed | TANC2 INPP4A RBMX SIPA1L1 PRICKLE2 BCAN SRGAP2 GRM5 PLEKHG5 RPH3A NDUFV1 HNRNPK | 3.46e-06 | 1431 | 58 | 12 | 37142655 | |
| Pubmed | PPIP5K2 and PCSK1 are Candidate Genetic Contributors to Familial Keratoconus. | 8.19e-06 | 3 | 58 | 2 | 31852976 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 34458856 | ||
| Pubmed | RBMX is a novel hepatic transcriptional regulator of SREBP-1c gene response to high-fructose diet. | 8.19e-06 | 3 | 58 | 2 | 17188681 | |
| Pubmed | The candidate spermatogenesis gene RBMY has a homologue on the human X chromosome. | 8.19e-06 | 3 | 58 | 2 | 10391206 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 16024054 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 12165565 | ||
| Pubmed | Leukocyte Cytoskeleton Polarization Is Initiated by Plasma Membrane Curvature from Cell Attachment. | 8.19e-06 | 3 | 58 | 2 | 30930167 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 27821480 | ||
| Pubmed | A novel splicing regulator shares a nuclear import pathway with SR proteins. | 8.19e-06 | 3 | 58 | 2 | 12628928 | |
| Pubmed | SAFB1, an RBMX-binding protein, is a newly identified regulator of hepatic SREBP-1c gene. | 1.64e-05 | 4 | 58 | 2 | 19403048 | |
| Pubmed | 1.98e-05 | 95 | 58 | 4 | 24029230 | ||
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 27522114 | ||
| Pubmed | 3.40e-05 | 109 | 58 | 4 | 29511296 | ||
| Pubmed | 3.59e-05 | 371 | 58 | 6 | 15747579 | ||
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 14595379 | ||
| Pubmed | HIV immune evasion disruption of antigen presentation by the HIV Nef protein. | 4.08e-05 | 6 | 58 | 2 | 21762823 | |
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 10982373 | ||
| Pubmed | Multiple receptors converge on H2-Q10 to regulate NK and γδT-cell development. | 4.08e-05 | 6 | 58 | 2 | 30537346 | |
| Pubmed | A nonpolymorphic class I gene in the murine major histocompatibility complex. | 4.08e-05 | 6 | 58 | 2 | 6420070 | |
| Pubmed | Identification of a recombinogenic major histocompatibility complex Q gene with diverse alleles. | 4.08e-05 | 6 | 58 | 2 | 8496692 | |
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 11932387 | ||
| Pubmed | Three classes of mouse H-2 messenger RNA distinguished by analysis of cDNA clones. | 4.08e-05 | 6 | 58 | 2 | 6276751 | |
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 9730897 | ||
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 8671651 | ||
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 2767053 | ||
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 6967411 | ||
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 9373217 | ||
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 7026427 | ||
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 19555986 | ||
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 9120272 | ||
| Pubmed | The dileucine-based sorting motif in HIV-1 Nef is not required for down-regulation of class I MHC. | 4.08e-05 | 6 | 58 | 2 | 10366557 | |
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 6411351 | ||
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 9582271 | ||
| Pubmed | Embryonal carcinoma cells express Qa and Tla class I genes of the major histocompatibility complex. | 4.08e-05 | 6 | 58 | 2 | 2740345 | |
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 6961454 | ||
| Pubmed | Organization of the AKR Qa region: structure of a divergent class I sequence, Q5k. | 4.08e-05 | 6 | 58 | 2 | 2639903 | |
| Pubmed | Characteristics of the expression of the murine soluble class I molecule (Q10). | 4.08e-05 | 6 | 58 | 2 | 3940270 | |
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 7836920 | ||
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 8283431 | ||
| Pubmed | QUOD ERAT FACIENDUM: sequence analysis of the H2-D and H2-Q regions of 129/SvJ mice. | 4.08e-05 | 6 | 58 | 2 | 12389096 | |
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 2416805 | ||
| Pubmed | Occurrence of a unique MHC class I gene in distantly related members of the genus Mus. | 4.08e-05 | 6 | 58 | 2 | 3988322 | |
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 9840288 | ||
| Pubmed | A single amino acid interchange yields reciprocal CTL specificities for HIV-1 gp160. | 4.08e-05 | 6 | 58 | 2 | 2789433 | |
| Pubmed | Spatial and functional relationship of GGAs and AP-1 in Drosophila and HeLa cells. | 4.08e-05 | 6 | 58 | 2 | 19847956 | |
| Pubmed | Correlation of Qa-1 determinants defined by antisera and by cytotoxic T lymphocytes. | 4.08e-05 | 6 | 58 | 2 | 2580784 | |
| Pubmed | Recognition of alternate alleles and mapping of the Qa1 locus. | 4.08e-05 | 6 | 58 | 2 | 7276576 | |
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 2228044 | ||
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 6304710 | ||
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 6822734 | ||
| Pubmed | Repression of MHC class I gene promoter activity by two-exon Tat of HIV. | 4.08e-05 | 6 | 58 | 2 | 8493575 | |
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 8732475 | ||
| Pubmed | Spatial-Temporal Expression of Non-classical MHC Class I Molecules in the C57 Mouse Brain. | 4.08e-05 | 6 | 58 | 2 | 26040564 | |
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 28894277 | ||
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 3925004 | ||
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 22503975 | ||
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 9368027 | ||
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 10546855 | ||
| Pubmed | Three regions of HIV-1 gp160 contain clusters of immunodominant CTL epitopes. | 4.08e-05 | 6 | 58 | 2 | 8877415 | |
| Pubmed | Qa antigens and their differential distribution on lymphoid, myeloid and stem cells. | 4.08e-05 | 6 | 58 | 2 | 6399516 | |
| Interaction | RBMY1J interactions | 1.71e-08 | 29 | 57 | 5 | int:RBMY1J | |
| Interaction | RBMY1F interactions | 5.33e-08 | 36 | 57 | 5 | int:RBMY1F | |
| Interaction | RBMY1E interactions | 8.56e-08 | 4 | 57 | 3 | int:RBMY1E | |
| Interaction | PCDHB14 interactions | 4.05e-07 | 22 | 57 | 4 | int:PCDHB14 | |
| Interaction | RBMY1A1 interactions | 1.95e-06 | 32 | 57 | 4 | int:RBMY1A1 | |
| Interaction | INPP5E interactions | 3.42e-05 | 65 | 57 | 4 | int:INPP5E | |
| Cytoband | Yq11.223 | 1.29e-07 | 93 | 58 | 5 | Yq11.223 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrYq11 | 4.72e-05 | 311 | 58 | 5 | chrYq11 | |
| Cytoband | 11q13 | 4.61e-04 | 118 | 58 | 3 | 11q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q15 | 8.72e-04 | 147 | 58 | 3 | chr15q15 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q22 | 5.60e-03 | 88 | 58 | 2 | chr17q22 | |
| GeneFamily | RNA binding motif containing | RBMXL1 RBM4B RBM4 RBMY1A1 RBMX RBMY1C RBMY1F RBMY1D RBMY1B RBMY1E | 5.69e-11 | 213 | 43 | 10 | 725 |
| GeneFamily | Glutamate metabotropic receptors|Protein phosphatase 1 regulatory subunits | 1.53e-04 | 8 | 43 | 2 | 281 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 3.35e-04 | 57 | 43 | 3 | 1179 | |
| GeneFamily | Zinc fingers CCHC-type|RNA binding motif containing | 1.60e-03 | 25 | 43 | 2 | 74 | |
| GeneFamily | C1-set domain containing | 4.48e-03 | 42 | 43 | 2 | 591 | |
| GeneFamily | Histocompatibility complex|C1-set domain containing | 4.91e-03 | 44 | 43 | 2 | 588 | |
| GeneFamily | Fibronectin type III domain containing | 6.48e-03 | 160 | 43 | 3 | 555 | |
| Coexpression | CHEN_ETV5_TARGETS_TESTIS | 7.84e-07 | 33 | 57 | 4 | MM701 | |
| Coexpression | ZHENG_IL22_SIGNALING_DN | 2.80e-06 | 45 | 57 | 4 | MM763 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-06 | 167 | 55 | 5 | a35ace2c722936d2a3e1f0826e5b6ec6b1340d2b | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.63e-05 | 139 | 55 | 4 | a1945b07f177cde40e7eea03a19236ce76165857 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.37e-05 | 148 | 55 | 4 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.55e-05 | 150 | 55 | 4 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.79e-05 | 162 | 55 | 4 | 373513f9d0e5007b2e10a8b78d4909dcce9e3b62 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.75e-05 | 177 | 55 | 4 | 16197068260fc062bf8b730a51a199887ea580b9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.36e-05 | 181 | 55 | 4 | 22363c5835dd6cef8f895ab9362e0837d92b15b1 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.52e-05 | 182 | 55 | 4 | a8cc56f32efe180e8fb5d69dbe606a794b3db700 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.85e-05 | 184 | 55 | 4 | d33de57876817050b294f2ecb0a4eb0634cfa7f0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.52e-05 | 188 | 55 | 4 | 3cee9916399e2e7580cecbcbb27424a71e7e7ac0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.70e-05 | 189 | 55 | 4 | e059be2965cca70ff5576df055d0af1775b76e00 | |
| ToppCell | Control|World / Disease condition and Cell class | 9.43e-05 | 193 | 55 | 4 | 92347e919c8425f33692e121df6ca5d841748f6c | |
| ToppCell | Striatum-Neuronal-Excitatory|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.00e-04 | 196 | 55 | 4 | 67400193ba469cf4d939e94f5ed94995e384bc07 | |
| ToppCell | Healthy_donor-NK|World / disease group, cell group and cell class (v2) | 1.04e-04 | 198 | 55 | 4 | 4c9c40e91173836ad0df2eba635a4cb3385e80c6 | |
| ToppCell | Healthy/Control-NK|World / Disease group and Cell class | 1.06e-04 | 199 | 55 | 4 | 87af9c38938dc2db0f9cf9f3676895d2a8b5d7e6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.06e-04 | 199 | 55 | 4 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Healthy/Control-NK|Healthy/Control / Disease group and Cell class | 1.06e-04 | 199 | 55 | 4 | e7fd91080fca7c31a2d48433791da3c2a4adf14d | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.06e-04 | 199 | 55 | 4 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.06e-04 | 199 | 55 | 4 | df4f7d5be099e3e6054f3b812ccf70251664e4c0 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.06e-04 | 199 | 55 | 4 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC-NK_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.06e-04 | 199 | 55 | 4 | ed35d747f11f6ea6a5cb7061057f0a98d9e0db99 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.06e-04 | 199 | 55 | 4 | 59915b6db86fd0cc83a0bf9a3a1dda08522ec8d3 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Myeloid-Dendritic_cells-pDC|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.08e-04 | 200 | 55 | 4 | 6a34e07e6d77fe3fdd9ff44c4b1e46a023f6d6a2 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-gd_T|COVID-19_Severe / Disease, condition lineage and cell class | 1.08e-04 | 200 | 55 | 4 | f72bc3f6606ae77fe1b0a972e35b3ce0727804d9 | |
| Drug | hydantoin-5-propionic acid | 2.05e-07 | 21 | 57 | 4 | CID000000782 | |
| Drug | AZFd | 3.02e-07 | 23 | 57 | 4 | CID000196489 | |
| Drug | azafagomine | 3.12e-07 | 57 | 57 | 5 | CID011957435 | |
| Drug | 5-aza-2'-deoxycytidine | FBN2 RASGRF2 RBMY1A1 RBMY1D RBMY1B RBMY1E GRM5 GRM7 LRP1B HNRNPK PRTFDC1 | 4.39e-07 | 638 | 57 | 11 | CID000016886 |
| Drug | thioglycolate | 7.05e-07 | 67 | 57 | 5 | CID000001133 | |
| Drug | Vistar | 1.96e-06 | 36 | 57 | 4 | CID000040896 | |
| Drug | 2-chlorodideoxyadenosine | 4.05e-06 | 43 | 57 | 4 | CID000072194 | |
| Drug | PKI166 | 6.33e-06 | 48 | 57 | 4 | CID006918403 | |
| Drug | HgCl | 6.88e-06 | 49 | 57 | 4 | CID000024182 | |
| Drug | SU6668 | 2.86e-05 | 70 | 57 | 4 | CID000206042 | |
| Drug | p11-13 | 3.76e-05 | 75 | 57 | 4 | CID000015759 | |
| Drug | oligoadenylate | 4.59e-05 | 157 | 57 | 5 | CID000107918 | |
| Disease | graft-versus-host disease (implicated_via_orthology) | 6.61e-05 | 7 | 53 | 2 | DOID:0081267 (implicated_via_orthology) | |
| Disease | insomnia measurement | 1.40e-04 | 443 | 53 | 6 | EFO_0007876 | |
| Disease | response to statin, myopathy | 1.72e-04 | 11 | 53 | 2 | EFO_0004145, GO_0036273 | |
| Disease | severe aplastic anemia | 3.27e-04 | 15 | 53 | 2 | EFO_0006927 | |
| Disease | Attention Deficit Disorder | 7.15e-04 | 22 | 53 | 2 | C0041671 | |
| Disease | Minimal Brain Dysfunction | 7.15e-04 | 22 | 53 | 2 | C1321905 | |
| Disease | obsolete Mendelian syndromes with cleft lip/palate | 7.82e-04 | 23 | 53 | 2 | MONDO_0015335 | |
| Disease | neurotic disorder | 8.05e-04 | 101 | 53 | 3 | EFO_0004257 | |
| Disease | Attention deficit hyperactivity disorder | 8.52e-04 | 24 | 53 | 2 | C1263846 | |
| Disease | Left ventricular mass to end-diastolic volume ratio | 9.25e-04 | 25 | 53 | 2 | EFO_0010556 | |
| Disease | myeloperoxidase measurement | 1.00e-03 | 26 | 53 | 2 | EFO_0005243 | |
| Disease | coronary artery calcification | 1.27e-03 | 450 | 53 | 5 | EFO_0004723 | |
| Disease | MITOCHONDRIAL COMPLEX I DEFICIENCY | 1.33e-03 | 30 | 53 | 2 | C1838979 | |
| Disease | alcohol consumption measurement | 1.58e-03 | 1242 | 53 | 8 | EFO_0007878 | |
| Disease | mitochondrial metabolism disease (implicated_via_orthology) | 1.81e-03 | 35 | 53 | 2 | DOID:700 (implicated_via_orthology) | |
| Disease | platelet component distribution width | 2.27e-03 | 755 | 53 | 6 | EFO_0007984 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AEGRFSGGCLPVYMR | 106 | Q6XXX2 | |
| FYRGSPGCVMDAVLR | 231 | Q9Y576 | |
| YSAMERPDGLGAAAG | 6 | Q6VUC0 | |
| ARGPRMSYGGSTCHA | 406 | P0DJD3 | |
| ARGPRMSYGGSTCHA | 406 | A6NDE4 | |
| ARGPRMSYGGSTCHA | 406 | P0DJD4 | |
| ARGPRMSYGGSTCHA | 406 | P0C7P1 | |
| ARGPRMSYGGSTCHA | 406 | A6NEQ0 | |
| ARGPRMSYGGSTCHA | 406 | Q15415 | |
| RTAPGMGDQSGCYRC | 151 | Q9BWF3 | |
| MAGSSEEAPDYGRGV | 1 | Q9NRG1 | |
| GMGGRAPVSRGRDSY | 176 | P38159 | |
| GGGRTGYIPCNMVAE | 1676 | O95153 | |
| GCDMGPDGRLLRGYH | 121 | P30511 | |
| GGAICRMYRFPTTDG | 226 | Q96PE3 | |
| REACYGDMDGFPGVR | 221 | Q96GW7 | |
| GYAGLCDAMKPIDGR | 421 | P41594 | |
| RSHACEVDPYGMPGG | 471 | Q9NZR2 | |
| QGGMPRASYGDRHCI | 301 | Q6P1M3 | |
| GYVDAGAEPGRSRMI | 341 | Q643R3 | |
| CSERYEARGAGAMPG | 76 | Q6PRD1 | |
| DGYAGLFERMCRLAG | 226 | Q8NBH2 | |
| GASCVGRMDRLGYPR | 686 | Q9H7Z3 | |
| RTAPGMGDQSGCYRC | 151 | Q9BQ04 | |
| SMYGCDVGPDGRLLR | 121 | P01889 | |
| MGHGSRRDLYGQCPR | 736 | Q7Z3G6 | |
| YDGPRQMGRYCGVDL | 1341 | O60494 | |
| CEPGYDLRGAASMRC | 326 | P17927 | |
| CEPGYDLRGAASMRC | 776 | P17927 | |
| GYCAMISRIPRGAFE | 181 | Q9Y375 | |
| MSDSAGGRAGLRRYP | 1 | Q49AR2 | |
| MGCGGSRADAIEPRY | 1 | Q8WXS3 | |
| PAGFQVYCDMRTDGG | 266 | Q8N539 | |
| GPGDCRGARGDTYAV | 241 | O15037 | |
| ADYRGVCPEMEQAGG | 431 | Q14831 | |
| GYALMPDGRSCADID | 1271 | P35556 | |
| GGGEARPCYDVIMFD | 561 | Q8N6R0 | |
| GRGGEPRAYFMSDTR | 421 | P05060 | |
| YEDSRGRRFMCSGPD | 851 | Q8ND04 | |
| VGGYPAVGAREDRMS | 336 | Q9Y2J0 | |
| GMGGRAPLSRGRDSY | 176 | Q96E39 | |
| GEQSCRPAGMYLLEG | 56 | O14827 | |
| GCLVGGRAMGARAAY | 141 | P49821 | |
| RGRPGDRYDGMVGFS | 326 | P61978 | |
| VMSCPYFRNEIGGEG | 411 | O43166 | |
| DYSGMRPLDRAVGCR | 1196 | Q9HCD6 | |
| REDAGAVCDGMPLGY | 396 | A1L4H1 | |
| GYMGRRCQAEVDCGP | 686 | Q8TER0 | |
| GPVDGRSCSMDSAYG | 806 | O94827 | |
| RSPGGGRDCMVCFES | 461 | A1L020 | |
| SRGGSMEDYCDSPHG | 691 | O75044 | |
| PRMLCAGYLDGRADA | 386 | Q9H3S3 | |
| DRVQCAGGPRKGYMG | 451 | Q9UPN7 | |
| GGVAMDVERSRFPYC | 41 | Q9H0R3 | |
| GGCMGPASRLQDGEY | 31 | P31314 | |
| CMTFPARGCDGAARG | 326 | Q96NZ8 | |
| LGRAFRCMYPGGQGD | 526 | O43314 | |
| GMGAVGGTPSDCRYI | 836 | Q06418 | |
| EELGRAFRCMYPGGQ | 536 | Q6PFW1 |